Last updated: 2026-09-22 17:32:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $268.43, with a market capitalization of $650.65B and a P/E ratio of 30.87. Over the past 52 weeks, its price has ranged from $174.12 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$650.65B | |
$267.51 | |
$281.07 | |
$46.25 | |
$269.47 | |
2.21M | |
7.42M | |
30.87 | |
$281.07 | |
$174.12 | |
1.94% | |
-- |
Johnson & Johnson (JNJ) is currently trading at $268.43 as of 2026-09-22 17:16:57, down 0.39% ($1.04) from the previous close of $269.47
During today's regular trading session, JNJ has traded between $46.25 and $281.07, with a trading volume of 2.21M shares. The current price is near the upper end of today's range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $265.58 to $268.43, representing a gain of 1.07% ($2.85).
The stock traded between $260.68 and $273.73 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 6.73 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 88.2%
JNJ is currently trading at $268.43, placing it 88.2% of the way from its 52-week low of $174.12 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.